1. 1459PWhich of afatinib and gefitinib/erlotinib is the better EGFR-TKI to be followed by osimertinib?. (23rd October 2018) Authors: Tamiya, M; Tamiya, A; Suzuki, H; Nakahama, K; Taniguchi, Y; Kunimasa, K; Kimura, M; Inoue, T; Nishino, K; Hirashima, T; Atagi, S; Imamura, F; Kumagai, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 540PClinical outcomes in non–small cell lung cancer patients with ultra-high expression of programmed death ligand-1 treated with pembrolizumab as first-line therapy: A retrospective multicenter cohort study. (25th November 2018) Authors: Kurebe, H; Edahiro, R; Kanazu, M; Fujimoto, D; Tamiya, M; Tamiya, A; Suzuki, H; Hirano, K; Yokoyama, T; Morita, M; Fukuda, Y; Uchida, J; Makio, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 79P Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer. (15th December 2019) Authors: Enomoto, T; Tamiya, A; Matsumoto, K; Adachi, Y; Azuma, K; Inagaki, Y; Kouno, S; Taniguchi, Y; Saijo, N; Okishio, K; Atagi, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 83P Analysis of predictive factors in non-small cell lung cancer patients treated with nivolumab. (15th December 2019) Authors: Azuma, K; Tamiya, A; Adachi, Y; Enomoto, T; Kouno, S; Taniguchi, Y; Saijo, N; Okishio, K; Atagi, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of pembrolizumab on patients harboring uncommon epidermal growth factor receptor mutations. (7th March 2018) Authors: Taniguchi, Y; Tamiya, A; Ishii, S; Atagi, S Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Programmed death-ligand 1 expression in uncommon epidermal growth factor receptor mutation-positive non-small-cell lung cancer. (10th September 2018) Authors: Taniguchi, Y; Takeda, M; Tamiya, A; Kasai, T; Atagi, S Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗